Embryo donation is a unique and not frequently utilized family building option. Our goal was to generate conversations about the many ways to build a family, including embryo donation via compelling digital engagement. Our Thinking RESOLVE: The National Infertility Association tasked Spectrum with shaping and telling a very important story – the story of embryo [...]

Prior to 2010, very few people had heard of RNA Interference (RNAi) let alone engaged in  a conversation about it. Alnylam Pharmaceuticals, however, had been focused on the breakthrough discovery in biology — offering the opportunity to treat disease in a fundamentally new way by silencing disease-causing genes — since the early part of the [...]

Progeria, also known as Hutchinson-Gilford Progeria Syndrome (HGPS), is a rare, fatal genetic condition characterized by an appearance of accelerated aging in children. Children with Progeria die of the same heart disease that affects millions of normally aging adults (arteriosclerosis), but at an average age of 13 years. The Progeria Research Foundation (PRF) is the only [...]

The Military Health Research Forum (MHRF) is a scientific conference highlighting research studies funded by the Department of Defense’s Congressionally Directed Medical Research Programs (CDMRP), Peer Reviewed Medical, Gulf War Illness, Psychological Health and Traumatic Brain Injury Research Programs. Research supported by these programs addresses the healthcare needs of the Armed Forces and their families, [...]

Alzheimer’s disease (AD) ravages more than 25 million people around the world. It’s a slow and brutal killer – erasing personal memories and altering personalities and behaviors – leaving people little of the identity they’ve built over a lifetime.

When it comes to consumer products, innovation is the key. And communicating about the science behind the product helps target audiences understand that there’s more than marketing behind the innovation. But how do you explain that science to a consumer-level audience?

Heart failure kills more African Americans than any other ethnic group. But in 2005, this community received good news. Spectrum partnered with NitroMed, Inc. to announce the historic FDA approval and launch of BiDil®, the first drug approved to treat one specific ethnic group – African Americans.

We developed an online, interactive tool called My Breast Cancer Coach to help women hone in on information relevant to their type of breast cancer. “Coach” uses a nurse-guided questionnaire to collect information about the woman’s tumor type to develop a semi-customized report that provides detailed disease and treatment information specific to her type of breast cancer.

On behalf of a women’s health client, Spectrum constructed and successfully implemented a research program that’s ultimate goal was to underscore the importance of compliance, convenience and satisfaction of a once-monthly dosing option.

The Institute of Medicine of the National Academies (IoM) is the nation’s preeminent adviser to business leaders and policymakers on health and science policy issues. Spectrum has helped IoM communicate its research studies. One example is the report, Food Marketing to Children and Youth: Threat or Opportunity?